These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2298288

  • 1. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C, Dixit M, Hardy RE.
    Experientia; 1990 Jan 15; 46(1):91-4. PubMed ID: 2298288
    [Abstract] [Full Text] [Related]

  • 2. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J, Vosmiková K, Pospísil J, Poucková P.
    Bratisl Lek Listy; 1992 May 15; 93(5):222-4. PubMed ID: 1393642
    [Abstract] [Full Text] [Related]

  • 3. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM, Visser JJ, van Kamp GJ, Mensdorff-Pouilly S, van Dijk W, Hilgers J, Kenemans P.
    Tumour Biol; 1992 May 15; 13(3):121-32. PubMed ID: 1626178
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ, Senra-Varela A.
    Int J Biol Markers; 1995 May 15; 10(3):174-9. PubMed ID: 8551061
    [Abstract] [Full Text] [Related]

  • 5. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM, Schwartz MK.
    Ann Clin Lab Sci; 1983 May 15; 13(2):137-42. PubMed ID: 6859805
    [Abstract] [Full Text] [Related]

  • 6. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec 15; 28(12):1599-607. PubMed ID: 2077205
    [Abstract] [Full Text] [Related]

  • 7. The significance of serum lipid-bound sialic acid in bladder tumours.
    Oztokatli A, Ozkardeş H, Ovül E, Erol D.
    Int Urol Nephrol; 1992 Dec 15; 24(2):125-9. PubMed ID: 1624255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K, Bian M, Zhu D, Liu W, Siu S.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr 15; 17(2):128-32. PubMed ID: 7656393
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
    Polívková J, Vosmiková K, Horák L.
    Neoplasma; 1992 Apr 15; 39(4):233-6. PubMed ID: 1436234
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E, Chondros K, Kouvaris J, Kakari S, Papavassiliou K.
    Anticancer Res; 1992 Apr 15; 12(1):251-5. PubMed ID: 1567173
    [Abstract] [Full Text] [Related]

  • 16. Superoxide dismutase and lipid-bound sialic acid in sera from children with cancers and juvenile chronic arthritis.
    Maneva A, Michailova D, Sarbenova M, Christozova I, Taleva B.
    Eur J Cancer Prev; 1995 Oct 15; 4(5):429-35. PubMed ID: 7496331
    [Abstract] [Full Text] [Related]

  • 17. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
    Vivas I, Spagnuolo L, Palacios P.
    Gynecol Oncol; 1992 Aug 15; 46(2):157-62. PubMed ID: 1500016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation between lipid-associated sialic acid and tumor burden in melanoma.
    Buzaid AC, Sandler AB, Hayden CL, Scinto J, Poo WJ, Clark MB, Hotchkiss S.
    Int J Biol Markers; 1994 Aug 15; 9(4):247-50. PubMed ID: 7836804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.